LeukemiaBCL2 InhibitorsVenclexta coupons
Venclexta

Venclexta Coupons & Discount Card - Compare Prices Near You

Venetoclax, marketed under the name Venclexta, is a medication primarily used to treat certain blood and lymph node cancers such as acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL), and small lymphocytic lymphoma (SLL). It is particularly prescribed for older adults or individuals with specific medical conditions. This medication is typically taken orally once a day, either alone or alongside other chemotherapy or targeted treatments, depending on the patient's specific condition. Venclexta operates as a targeted therapy known as a BCL-2 inhibitor. The BCL-2 protein aids in the survival of cancer cells, and certain cancers, including AML and CLL/SLL, are characterized by an overproduction of this protein, leading to uncontrolled cell growth. By blocking BCL-2, venetoclax helps to kill and slow the growth of these cancer cells, effectively managing the disease. Patients should be aware that venetoclax can increase the risk of a serious condition known as tumor lysis syndrome (TLS). It is crucial to engage with healthcare professionals, such as doctors, nurses, or pharmacists, to receive personalized medical advice and ensure the medication's safe and effective use.
Our Venclexta coupons are free to use. You can print the coupon, email it to yourself, or receive the Venclexta coupon via text message. To get your free discount, show the pharmacist your Venclexta savings card which has the discounted coupon price. Use our filters below to edit the prescription box to match your needs. The Venclexta prices will update based on your prescription needs. Above our Venclexta coupons, you can change the location to see pharmacy prices in other areas. Our prescription discount card will update online with the specific pharmacy costs associated with your edits. Be sure to text, email, or print the Venclexta savings card code that you need after editing the prescription box and location field. Show the discount card to your pharmacist before paying.

My prescription

Edit

100MG, Venclexta (30 Tablets)

Select pharmacy

Pharmacy logo

Rite Aid

$3879.89

COUPON PRICE
Pharmacy logo

Walgreens

$4045.55

COUPON PRICE

Venclexta savings card

Show this card to your pharmacist
Pharmacy logo

Rite Aid

$3879.89

BIN

ID

PCN

GRP

019876

LHDCC292D3

CHIPPO

LHX

Powered by

This card is not insurance

More prescriptions for leukemia

coupons from$8.65Save 83%
coupons from$17218.39 
coupons from$4155.72Save 72%
coupons from$9738.74 
coupons from$6591.53Save 72%
coupons from$11273.76 
coupons from$1.01 
coupons from$5210.34Save 72%

More prescriptions for leukemia

Cytarabine Save 83%coupons from $8.65
Rezlidhiacoupons from $17218.39
Myleran Save 72%coupons from $4155.72
Xospatacoupons from $9738.74
Rydapt Save 72%coupons from $6591.53
Scemblixcoupons from $11273.76
Arsenic Trioxidecoupons from $1.01
Bosulif Save 72%coupons from $5210.34

Venclexta dosage forms

The average cost for 30 Tablets of Venclexta at 10MG is $395.12 with a free coupon. This is 2.81% off the average retail price of $14084.23
DosageQuantityPrice fromPer unit
10MG30 Tablets$395.12$13.17
50MG30 Tablets$1969.98$65.67
100MG30 Tablets$3937.49$131.25

Venclexta Warnings

This document outlines key safety information and warnings associated with the use of Venclexta (venetoclax). Please read carefully and discuss any concerns with your healthcare provider.

  • Tumor Lysis Syndrome (TLS): Venclexta may cause TLS, a dangerous condition where cancer cells die rapidly, releasing substances into the blood that can lead to high uric acid and electrolyte imbalances. This may result in kidney damage and abnormal heart rhythms. TLS risk is heightened at the start of treatment and with dose increases. Patients with kidney issues, high tumor burden, enlarged spleen, circulating blasts, or elevated LDH levels are at greater risk.

  • Low Blood Cell Counts: Venclexta can lower white and red blood cells and platelets, increasing the risk of anemia, bleeding, bruising, and infections. Regular blood count monitoring is essential. Report any signs of fever, illness, or unusual bleeding or bruising to your provider, as dosage adjustments may be necessary.

  • Infections: The risk of serious infections, including pneumonia and sepsis, is increased with Venclexta use, which can be life-threatening if untreated. Immediate medical attention is required if symptoms such as fever, chills, fatigue, or cough occur.

  • Vaccination Precautions: Avoid live vaccines before, during, and after Venclexta treatment unless approved by your healthcare provider, as they may cause infections in individuals with weakened immune systems. The effectiveness of vaccines may also be reduced.

  • Pregnancy Warning: Animal studies suggest that Venclexta may harm an unborn child. Women who can become pregnant should use effective contraception during treatment and for one month after the last dose. Notify your provider immediately if you become pregnant during this period.

  • Contraindications: Do not use Venclexta concurrently with strong CYP3A inhibitors during the initial and dose-escalation phases for CLL/SLL patients, as this increases the risk of TLS.

This information is crucial for safe and effective use of Venclexta. Always follow your healthcare provider’s instructions and report any adverse effects promptly.

Venclexta Side Effects

When taking this medication, some common side effects may occur, though they are generally mild and manageable. These include diarrhea, nausea, vomiting, tiredness, and headaches. It’s advisable to eat small meals and rest adequately to help mitigate these symptoms. Additionally, some people might experience muscle and joint pain, swelling in limbs, stomach pain, rash, or constipation. If any of these persist or worsen, consulting a healthcare provider is recommended.

More serious side effects, although less common, should be taken seriously. These include easy bruising or bleeding, a low count of white or red blood cells, and low platelet count, which might increase the risk of infections. Symptoms such as fever, sore throat, or persistent cough could indicate an infection. In very rare cases, severe allergic reactions like rash, swelling, or trouble breathing might occur, requiring immediate medical attention.

Another serious condition associated with this medication is tumor lysis syndrome, which can result from the rapid destruction of cancer cells. Symptoms may include fever, chills, muscle weakness, and changes in urine color. It is crucial to stay hydrated and monitor for any signs of kidney problems.

If you notice symptoms such as low blood pressure, dizziness, or painful mouth sores, it is important to seek medical advice. Always communicate any unusual or severe side effects to a healthcare provider to ensure appropriate care and monitoring.

Venclexta Interactions

Certain medications can influence how venetoclax is processed in your body, potentially altering its effectiveness. These include azole antifungals like itraconazole and ketoconazole, HIV protease inhibitors such as atazanavir, macrolide antibiotics like clarithromycin, rifamycins such as rifampin, the antiviral ritonavir, herbal supplements like St. John's wort, and seizure medications including carbamazepine and phenytoin. It's important to inform your healthcare provider of all medications you are taking to manage any potential interactions effectively.
Venclexta FAQs
Is VENCLEXTA considered chemotherapy?

VENCLEXTA (venetoclax) is not considered traditional chemotherapy. It is a targeted therapy known as a BCL-2 inhibitor, which works by helping to restore the process of apoptosis, or programmed cell death, in cancer cells.

VENCLEXTA is used for the treatment of certain types of blood cancers, specifically chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and acute myeloid leukemia (AML). It works by targeting and inhibiting a protein that helps cancer cells survive, thereby promoting their destruction.

VENCLEXTA (venetoclax) is not classified as an immunosuppressant. It is a medication used primarily in the treatment of certain types of blood cancers, such as chronic lymphocytic leukemia (CLL) and acute myeloid leukemia (AML). It works by inhibiting a protein called BCL-2, which helps cancer cells survive.

The chemotherapy pill commonly used for certain types of leukemia is Imatinib, also known by its brand name Gleevec. It is often used to treat chronic myeloid leukemia (CML) and some cases of acute lymphoblastic leukemia (ALL). Other oral chemotherapy options may include Dasatinib (Sprycel) and Nilotinib (Tasigna), depending on the specific type and characteristics of the leukemia.

The life expectancy of patients taking VENCLEXTA (venetoclax) can vary significantly based on several factors, including the type and stage of cancer being treated, the patient's overall health, response to treatment, and other individual circumstances. Clinical trials and studies provide data on progression-free survival and overall survival rates, but these are averages and may not predict individual outcomes. It is important for patients to discuss their specific prognosis with their healthcare provider, who can provide information tailored to their unique situation.